Bioassay research methodology: Measuring CRH in pregnancy

Biological Research for Nursing

Volumn 10, Issue 1, 2008, Pages 54-62

  Latendresse, Gwen ^a   Ruiz, Roberta Jeanne ^b  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Bioassay methodology; Corticotropin releasing hormone; Pregnancy

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; PRESERVATIVE;

ARTICLE; BLOOD; BLOOD SAMPLING; CHEMISTRY; CLINICAL NURSING RESEARCH; CLINICAL PROTOCOL; ECONOMICS; ENZYME LINKED IMMUNOSORBENT ASSAY; EVIDENCE BASED MEDICINE; FEMALE; HEMOLYSIS; HUMAN; METHODOLOGY; PATIENT SELECTION; PLASMA; PREGNANCY; PREGNANCY OUTCOME; RADIOIMMUNOASSAY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STANDARD; TEMPERATURE; TIME;

BLOOD SPECIMEN COLLECTION; CLINICAL NURSING RESEARCH; CLINICAL PROTOCOLS; CORTICOTROPIN-RELEASING HORMONE; ENZYME-LINKED IMMUNOSORBENT ASSAY; EVIDENCE-BASED MEDICINE; FEMALE; HEMOLYSIS; HUMANS; PATIENT SELECTION; PLASMA; PREGNANCY; PREGNANCY OUTCOME; PRESERVATIVES, PHARMACEUTICAL; RADIOIMMUNOASSAY; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; SENSITIVITY AND SPECIFICITY; TEMPERATURE; TIME FACTORS;

EID: 47649125611     PISSN: 10998004     EISSN: 15524175     Source Type: Journal    
DOI: 10.1177/1099800408320970     Document Type: Article

References (30)

1. Behan, D.P., Khongsaly, O., Liu, X.J., Ling, N., Goland, R., Nasman, B., et al. (1996). Measurement of corticotropin-releasing factor (CRF), CRF-binding protein (CRF-BP), and CRF/CRF-BP complex in human plasma by two-site enzyme-linked immunoabsorbant assay. The Journal of Clinical Endocrinology and Metabolism, 81, 2579-2586.
2. Challis, J.R.G., Matthews, S.G., Gibb, W., & Lye, S.J. (2000). Endocrine and paracrine regulation of birth at term and preterm. Endocrine Reviews,, 21, 514-550.
3. Chrousos, G.P. (2000). The HPA axis and the stress response. Endocrine Research, 26, 513-514.
4. Ellis, J., Livesey, J.H., & Evans, M.J. (2003). Hormone stability in human whole blood. Clinical Biochemistry, 36, 109-112.
5. Emanuel, R.L., Robinson, B.G., Seely, E.W., Graves, S.W., Kohane, I., Saltzman, D., et al. (1994). Corticotrophin releasing hormone levels in human plasma and amniotic fluid during gestation. Clinical Endocrinology (Oxford), 40, 257-262.
6. Erickson, K., Thorsen, P., Chrousos, G., Grigoriadis, D.E., Khongsaly, O., McGregor, J., et al. (2001). Preterm birth: Associated neuroendocrine, medical, and behavioral risk factors. The Journal of Clinical Endocrinology and Metabolism, 86, 2544-2552.
7. Evans, M.J., Livesey, J.H., Ellis, M.J., & Yandle, T.G. (2001). Effect of anticoagulants and storage temperatures on stability of plasma and serum hormones. Clinical Biochemistry, 34, 107-112.
8. Guder, W., Narayanan, S., Wisser, H., & Zawta, B. (2003). Samples: From the patient to the laboratory. The impact of preanalytical variables on the quality of laboratory samples (3 rd ed.). Weinheim, Germany: Wiley-VCH Verlog GmbH & Co.
9. Hobel, C.J., Arora, C.P., & Korst, L.M. (1999). Corticotrophin- releasing hormone and CRH-binding protein. Differences between patients at risk for preterm birth and hypertension. Annals of the New York Academy of Sciences, 897, 54-65.
10. Hobel, C.J., & Culhane, J. (2003). Role of psychosocial and nutritional stress on poor pregnancy outcome. Journal of Nutrition, 133 (5 Suppl 2). 1709S - 1717S.
11. Hobel, C.J., Dunkel-Schetter, C., Roesch, S.C., Castro, L.C., & Arora, C.P. (1999). Maternal plasma corticotropin-releasing hormone associated with stress at 20 weeks' gestation in pregnancies ending in preterm delivery. American Journal of Obstetrics and Gynecology, 180 (1 Pt 3). S257 - S263.
12. Holzman, C., Jetton, J., Siler-Khodr, T., Fisher, R., & Rip, T. (2001). Second trimester corticotropin-releasing hormone levels in relation to preterm delivery and ethnicity. Obstetrics and Gynecology, 97 (5 Pt 1). 657-663.
13. Linton, E.A., Perkins, A.V., Hagan, P., Poole, S., Bristow, A.F., Tilders, F., et al. (1995). Corticotrophin-releasing hormone (CRH)-binding protein interference with CRH antibody binding: Implications for direct CRH immunoassay. Journal of Endocrinology, 146, 45-53.
14. Lockwood, C.J., & Kuczynski, E. (2001). Risk stratification and pathological mechanisms in preterm delivery. Paediatric and Perinatal Epidemiology, 15 (Suppl 2). 78-89.
15. Lockwood, C.J., Radunovic, N., Nastic, D., Petkovic, S., Aigner, S., & Berkowitz, G.S. (1996). Corticotropin-releasing hormone and related pituitary-adrenal axis hormones in fetal and maternal blood during the second half of pregnancy. Journal of Perinatal Medicine, 24, 243-251.
16. Mancuso, R.A., Schetter, C.D., Rini, C.M., Roesch, S.C., & Hobel, C.J. (2004). Maternal prenatal anxiety and corticotropin-releasing hormone associated with timing of delivery. Psychosomatic Medicine,, 66, 762-769.
17. McGrath, S., McLean, M., Smith, D., Bisits, A., Giles, W., & Smith, R. (2002). Maternal plasma corticotropin-releasing hormone trajectories vary depending on the cause of preterm delivery. American Journal of Obstetrics and Gynecology, 186, 257-260.
18. McLean, M., & Smith, R. (2001). Corticotrophin-releasing hormone and human parturition. Reproduction, 121, 493-501.
19. Norwitz, E.R., Robinson, J.N., & Challis, J.R. (1999). The control of labor. New England Journal of Medicine, 341, 660-666.
20. Peninsula (2006). General protocol for peptide radioimmunoassay. San Carlos, CA: Peninsula Laboratories, Inc.
21. Petraglia, F., Genazzani, A.D., Aguzzoli, L., Gallinelli, A., de Vita, D., Caruso, A., et al. (1994). Pulsatile fluctuations of plasma-gonadotropin- releasing hormone and corticotropin-releasing factor levels in healthy pregnant women. Acta Obstetricia et Gynecologica Scandinavica, 73, 284-289.
22. Ruiz, R.J., Fullerton, J., Brown, C.E., & Dudley, D.J. (2002). Predicting risk of preterm birth: The roles of stress, clinical risk factors, and corticotropin-releasing hormone. Biological Research for Nursing, 4, 54-64.
23. Sandman, C.A., Glynn, L., Schetter, C.D., Wadhwa, P., Garite, T., Chicz-DeMet, A., et al. (2006). Elevated maternal cortisol early in pregnancy predicts third trimester levels of placental corticotropin releasing hormone (CRH): Priming the placental clock. Peptides, 27, 1457-1463.
24. Sibai, B., Meis, P.J., Klebanoff, M., Dombrowski, M.P., Weiner, S.J., Moawad, A.H., et al. (2005). Plasma CRH measurement at 16 to 20 weeks' gestation does not predict preterm delivery in women at high-risk for preterm delivery. American Journal of Obstetrics and Gynecology, 193 (3 Pt 2). 1181-1186.
25. Siler-Khodr, T.M., Forthman, G., Khodr, C., Matyszczyk, S., Khodr, Z., & Khodr, G. (2003). Maternal serum corticotropin-releasing hormone at midgestation in Hispanic and White women. Obstetrics and Gynecology, 101, 557-564.
26. Smith, R., Mesiano, S., & McGrath, S. (2002). Hormone trajectories leading to human birth. Regulatory Peptides, 108, 159-164.
27. Sorem, K.A., Smikle, C.B., Spencer, D.K., Yoder, B.A., Graveson, M.A., & Siler-Khodr, T.M. (1996). Circulating maternal corticotropin-releasing hormone and gonadotropin-releasing hormone in normal and abnormal pregnancies. American Journal of Obstetrics and Gynecology, 175 (4 Pt 1). 912-916.
28. Strong, E.F., Kleinman, K.P., Gillman, M.W., Clark, I., Emanuel, R.L., Majzoub, J.A., et al. (2006). Measuring corticotropin-releasing hormone in pregnant women-comparing blood collection protocols for epidemiological studies. Paediatric and Perinatal Epidemiology, 20, 67-71.
29. Torricelli, M., Ignacchiti, E., Giovannelli, A., Merola, A., Scarpetti, E., Calonaci, G., et al. (2006). Maternal plasma corticotrophin-releasing factor and urocortin levels in post-term pregnancies. European Journal of Endocrinology, 154, 281-285.
30. Wadhwa, P.D., Garite, T.J., Porto, M., Glynn, L., Chicz-DeMet, A., Dunkel-Schetter, C., et al. (2004). Placental corticotropin-releasing hormone (CRH), spontaneous preterm birth, and fetal growth restriction: A prospective investigation. American Journal of Obstetrics and Gynecology, 191, 1063-1069.